The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies
- 1 November 2022
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 249, 74-84
Abstract
No abstract availableKeywords
Funding Information
- Administration for Community Living (K23MH106683, R01118484)
- National Institute of Mental Health (R01MH102951, R01MH112800)
This publication has 66 references indexed in Scilit:
- Towards a glutamate hypothesis of depressionNeuropharmacology, 2012
- Proton magnetic resonance spectroscopy and thought disorder in childhood schizophreniaSchizophrenia Research, 2011
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for TreatmentNeuropsychopharmacology, 2011
- Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 TeslaBiological Psychiatry, 2011
- Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodromeSchizophrenia Research, 2010
- Assessments of Function and Biochemistry of the Anterior Cingulate Cortex in SchizophreniaBiological Psychiatry, 2010
- A Brief Cognitive Assessment Tool for Schizophrenia: Construction of a Tool for CliniciansSchizophrenia Bulletin, 2009
- Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and BeyondSchizophrenia Bulletin, 2009
- White Matter Alterations in Deficit SchizophreniaNeuropsychopharmacology, 2008
- Brain Metabolite Abnormalities in the White Matter of Elderly Schizophrenic Subjects: Implication for Glial DysfunctionBiological Psychiatry, 2007